Cargando…
Comparing long-term outcomes between endoscopic submucosal dissection (ESD) and endoscopic mucosal resection (EMR) for type II esophagogastric junction neoplasm
BACKGROUND: Endoscopic submucosal dissection (ESD) and endoscopic mucosal resection (EMR) are used to remove esophagogastric junction (EGJ) neoplasm. This study aimed to compare feasibility, safety, and effectiveness between ESD and EMR to help endoscopists choose treatment methods. METHODS: A total...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7944311/ https://www.ncbi.nlm.nih.gov/pubmed/33708949 http://dx.doi.org/10.21037/atm-20-4265 |
_version_ | 1783662663263322112 |
---|---|
author | Liu, Yong He, Shun Zhang, Yueming Dou, Lizhou Liu, Xiao Yu, Xinying Lu, Ning Xue, Liyan Wang, Guiqi |
author_facet | Liu, Yong He, Shun Zhang, Yueming Dou, Lizhou Liu, Xiao Yu, Xinying Lu, Ning Xue, Liyan Wang, Guiqi |
author_sort | Liu, Yong |
collection | PubMed |
description | BACKGROUND: Endoscopic submucosal dissection (ESD) and endoscopic mucosal resection (EMR) are used to remove esophagogastric junction (EGJ) neoplasm. This study aimed to compare feasibility, safety, and effectiveness between ESD and EMR to help endoscopists choose treatment methods. METHODS: A total of 130 patients with EGJ neoplasm underwent endoscopic resection, including 52 patients with EMR and 78 patients with ESD. Cap-assisted EMR (EMRC) was performed with typical sequences. Larger lesions required removal in multiple pieces (i.e., piecemeal EMR). The ESD procedures were included that marking the periphery of the lesion, submucosa injected, circumferentially cutting and submucosal dissection. Resection time, adverse events, en bloc resection rate, R0 resection rate and recurrence rate were compared between the two groups. RESULTS: There were no significant differences in demographic characteristics or histopathological features between the two groups. Resection time was longer in the ESD group than in the EMR group (64.4±33.9 vs. 22.1±8.0 minutes; P<0.01). Adverse events were more common in the ESD group than in the EMR group (16.7% vs. 3.8%; P=0.03), including bleeding (7.7% vs. 3.8%), perforation (5.1% vs. 0%) and stenosis (5.1% vs. 0%). The en bloc resection rate and R0 resection rate were much higher in the ESD group than in the EMR group (98.7% and 92.3% vs. 23.1% and 23.1%, respectively; P<0.01). The 5-year overall survival rate and disease-free survival rate were 100% vs. 92.0% and 100% vs. 90.1% between the ESD and EMR groups, respectively (P=0.01 and P=0.01). The 5-year cancer-specific survival rate was 100% vs. 96.0% between the ESD and EMR groups (P=0.08). The recurrence rate was lower in the ESD group than in the EMR group (0% vs. 9.6%; P=0.01). CONCLUSIONS: ESD is an acceptable first-line endoscopic treatment for type II EGJ neoplasm, however, it is time-consuming and has a higher rate of adverse events. Furthermore, EMR is a safe and alternative technique, particularly when EMR could achieve en bloc resection. |
format | Online Article Text |
id | pubmed-7944311 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-79443112021-03-10 Comparing long-term outcomes between endoscopic submucosal dissection (ESD) and endoscopic mucosal resection (EMR) for type II esophagogastric junction neoplasm Liu, Yong He, Shun Zhang, Yueming Dou, Lizhou Liu, Xiao Yu, Xinying Lu, Ning Xue, Liyan Wang, Guiqi Ann Transl Med Original Article BACKGROUND: Endoscopic submucosal dissection (ESD) and endoscopic mucosal resection (EMR) are used to remove esophagogastric junction (EGJ) neoplasm. This study aimed to compare feasibility, safety, and effectiveness between ESD and EMR to help endoscopists choose treatment methods. METHODS: A total of 130 patients with EGJ neoplasm underwent endoscopic resection, including 52 patients with EMR and 78 patients with ESD. Cap-assisted EMR (EMRC) was performed with typical sequences. Larger lesions required removal in multiple pieces (i.e., piecemeal EMR). The ESD procedures were included that marking the periphery of the lesion, submucosa injected, circumferentially cutting and submucosal dissection. Resection time, adverse events, en bloc resection rate, R0 resection rate and recurrence rate were compared between the two groups. RESULTS: There were no significant differences in demographic characteristics or histopathological features between the two groups. Resection time was longer in the ESD group than in the EMR group (64.4±33.9 vs. 22.1±8.0 minutes; P<0.01). Adverse events were more common in the ESD group than in the EMR group (16.7% vs. 3.8%; P=0.03), including bleeding (7.7% vs. 3.8%), perforation (5.1% vs. 0%) and stenosis (5.1% vs. 0%). The en bloc resection rate and R0 resection rate were much higher in the ESD group than in the EMR group (98.7% and 92.3% vs. 23.1% and 23.1%, respectively; P<0.01). The 5-year overall survival rate and disease-free survival rate were 100% vs. 92.0% and 100% vs. 90.1% between the ESD and EMR groups, respectively (P=0.01 and P=0.01). The 5-year cancer-specific survival rate was 100% vs. 96.0% between the ESD and EMR groups (P=0.08). The recurrence rate was lower in the ESD group than in the EMR group (0% vs. 9.6%; P=0.01). CONCLUSIONS: ESD is an acceptable first-line endoscopic treatment for type II EGJ neoplasm, however, it is time-consuming and has a higher rate of adverse events. Furthermore, EMR is a safe and alternative technique, particularly when EMR could achieve en bloc resection. AME Publishing Company 2021-02 /pmc/articles/PMC7944311/ /pubmed/33708949 http://dx.doi.org/10.21037/atm-20-4265 Text en 2021 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
spellingShingle | Original Article Liu, Yong He, Shun Zhang, Yueming Dou, Lizhou Liu, Xiao Yu, Xinying Lu, Ning Xue, Liyan Wang, Guiqi Comparing long-term outcomes between endoscopic submucosal dissection (ESD) and endoscopic mucosal resection (EMR) for type II esophagogastric junction neoplasm |
title | Comparing long-term outcomes between endoscopic submucosal dissection (ESD) and endoscopic mucosal resection (EMR) for type II esophagogastric junction neoplasm |
title_full | Comparing long-term outcomes between endoscopic submucosal dissection (ESD) and endoscopic mucosal resection (EMR) for type II esophagogastric junction neoplasm |
title_fullStr | Comparing long-term outcomes between endoscopic submucosal dissection (ESD) and endoscopic mucosal resection (EMR) for type II esophagogastric junction neoplasm |
title_full_unstemmed | Comparing long-term outcomes between endoscopic submucosal dissection (ESD) and endoscopic mucosal resection (EMR) for type II esophagogastric junction neoplasm |
title_short | Comparing long-term outcomes between endoscopic submucosal dissection (ESD) and endoscopic mucosal resection (EMR) for type II esophagogastric junction neoplasm |
title_sort | comparing long-term outcomes between endoscopic submucosal dissection (esd) and endoscopic mucosal resection (emr) for type ii esophagogastric junction neoplasm |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7944311/ https://www.ncbi.nlm.nih.gov/pubmed/33708949 http://dx.doi.org/10.21037/atm-20-4265 |
work_keys_str_mv | AT liuyong comparinglongtermoutcomesbetweenendoscopicsubmucosaldissectionesdandendoscopicmucosalresectionemrfortypeiiesophagogastricjunctionneoplasm AT heshun comparinglongtermoutcomesbetweenendoscopicsubmucosaldissectionesdandendoscopicmucosalresectionemrfortypeiiesophagogastricjunctionneoplasm AT zhangyueming comparinglongtermoutcomesbetweenendoscopicsubmucosaldissectionesdandendoscopicmucosalresectionemrfortypeiiesophagogastricjunctionneoplasm AT doulizhou comparinglongtermoutcomesbetweenendoscopicsubmucosaldissectionesdandendoscopicmucosalresectionemrfortypeiiesophagogastricjunctionneoplasm AT liuxiao comparinglongtermoutcomesbetweenendoscopicsubmucosaldissectionesdandendoscopicmucosalresectionemrfortypeiiesophagogastricjunctionneoplasm AT yuxinying comparinglongtermoutcomesbetweenendoscopicsubmucosaldissectionesdandendoscopicmucosalresectionemrfortypeiiesophagogastricjunctionneoplasm AT luning comparinglongtermoutcomesbetweenendoscopicsubmucosaldissectionesdandendoscopicmucosalresectionemrfortypeiiesophagogastricjunctionneoplasm AT xueliyan comparinglongtermoutcomesbetweenendoscopicsubmucosaldissectionesdandendoscopicmucosalresectionemrfortypeiiesophagogastricjunctionneoplasm AT wangguiqi comparinglongtermoutcomesbetweenendoscopicsubmucosaldissectionesdandendoscopicmucosalresectionemrfortypeiiesophagogastricjunctionneoplasm |